Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Starts & Stops: Abbott, Medtronic Announce Major Trial Activities

Executive Summary

Starts & Stops is a regular feature highlighting Medtech Insight editors' picks of noteworthy medtech clinical trial announcements, initiations, completions, and suspensions each month. This edition includes entries from a variety of companies and technologies, including many post-market studies following regulatory approvals.

Advertisement

Related Content

Abiomed, FDA Attribute High Mortality In Impella RP Post-Market Data To Patient Selection
Resilience Is Key For Medtechs Facing Provider And Payer Flux In 2018
Abbott Gains Go-Ahead For First 'No-Fingerstick' CGM
OUS Approvals: Cardiovascular Devices Lead Modest List In July
Impella Sales Drive Abiomed F2016 Q2 Revenues Up 47%

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT121567

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel